Role of alkaloid compounds in regulating chronic liver diseases
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 2
Abstract
Chronic liver diseases with common causes including viral infections， alcohol abuse， and autoimmune diseases. Alkaloids， as a class of plant-derived compounds， have shown significant potential in regulating chronic liver diseases. Recent studies have shown that alkaloids are able to exert a therapeutic effect on chronic liver diseases through multiple pathways. These compounds have a regulatory effect on key pathological processes such as liver fibrosis， inflammatory response， oxidative stress， and cell apoptosis， and they also regulate the metabolic homeostasis of hepatocytes by modulating multiple signaling pathways， thereby playing a role in regulating chronic liver diseases. This article reviews the role and mechanism of alkaloids in the treatment of chronic liver diseases， in order to provide new ideas and directions for the treatment of chronic liver diseases.
Authors and Affiliations
Yihui ZHENG, Jiahui WANG, Tiejian ZHAO, Xuelin DUAN, Lei WANG, Yang ZHENG, Shiquan YANG
Keywords
Related Articles
- EP ID EP768432
- DOI 10.12449/JCH250227
- Views 5
- Downloads 0
Role of triggering receptor expressed on myeloid cells 2 in acute and chronic liver diseases
Triggering receptor expressed on myeloid cells 2 （TREM2） is expressed in resident non-parenchymal cells （NPCs） and is involved in various pathological processes including liver inflammation and immunoregulation. In r...
Effect of Biejia Decoction Pill on aerobic glycolysis in hepatocellular carcinoma by regulating the protein kinase B/mammalian target of rapamycin signaling pathway
[Objective] To investigate the inhibitory effect of Biejia Decoction Pill on the proliferation， migration， and aerobic glycolysis of hepatocellular carcinoma （HCC） using cell experiments， as well as related mechanis...
Characteristics of cardiometabolic risk in patients with different subtypes of non-alcoholic fatty liver disease
[Objective] To investigate the difference in the risk of cardiovascular diseases between patients with different subtypes of non-alcoholic fatty liver disease （NAFLD） from the perspective of metabolism， since cardiova...
Association between intestinal barrier disruption in liver failure and the cGAS-STING signaling pathway
Liver failure is a common severe syndrome of liver diseases with high mortality. The function and structural integrity of the intestinal barrier as an entity are closely associated with the development and progression of...
Risk factors for liver cancer in chronic hepatitis B patients and construction of a nomogram prediction model
[Objective] To investigate the risk factors for liver cancer in patients with chronic hepatitis B （CHB） in the Qidong Chronic Hepatitis B cohort， and to construct a nomogram model for predicting the risk of liver canc...